Direxion Daily S&P Biotech Bear 3X Shares ETF
LABD NYSE Arca
The Direxion Daily S&P Biotech Bear 3X Shares seek daily investment results, before fees and expenses, of 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. This leveraged ETF seeks a return that is -300% the return of its benchmark index for a sin...
Hover to inspectDrag to measure a move← → to step through days
- Fund size
- 161M as of Feb 2020
- Expense ratio
- 1.11% per year
- Dividend yield
- 5.86% Yearly
- Volatility · 1Y
- 87.0% High Risk
- Beta
- -2.89 vs the market
- 52-week range
- 5.8433.85
How LABD has paid off
Price return over every period, and total return with dividends reinvested, set against price alone.
Return by period
Price · to Oct 12Total return vs price return
Price onlyOver 1 year, LABD returned −75.3% with dividends reinvested — dividends added +1.4 pts to the price move.
How bumpy is the ride?
Return only means something next to the risk taken to earn it. Volatility, drawdowns and market sensitivity over 1 year.
Volatility
Annualized · 1YA typical year sees the price swing about ±87% around its trend.
Drawdown from peak
How far below its previous high the price has been Deepest fall −82.8% on Aug 25, 2026 — 315 days after the previous high
More than 5% below a high 99% of the time.
Market sensitivity
BetaA beta of -2.89 means LABD has moved less than the market.
Trend & momentum
Where the price sits against its moving averages, and how stretched the recent move is.
Price vs moving averages
Downtrend- 12-day average7.61 +3.3%
- 26-day average7.41 +6.1%
- 50-day average7.63 +3.0%
- 200-day average15.97 −50.8%
The price is above 3 of 4 averages. The 50-day average is below the 200-day, a sign of a falling longer-term trend.
Relative strength (RSI)
NeutralRSI compares recent gains with recent losses on a 0–100 scale. Above 70 a move is often considered stretched, below 30 washed out.
Technical indicators describe past prices. They are not a forecast.
Inside the fund
Health Care · Inverse — tracking the S&P Biotechnology Select Industry Index.
- Assets under management161MUSD
- Expense ratio1.11%per year
- Holdings16
- Risk score7.8High
Launched May 2015. Listed options available. Fund data as of Feb 27, 2020.
What it pays you
Cash distributions over the last twelve months, and how they have grown.
About 59 USD a year for every 1,000 USD invested at today's price.
- Per share
- 0.46
- Frequency
- Yearly
- Last paid
- Sep 22, 2026
Last 12 months
0.46 USD / shareWhere LABD shows up
Curated themes and indices that hold LABD. Open one to see it in context, or test the whole theme in a portfolio.
About Direxion Daily S&P Biotech Bear 3X Shares ETF
The Direxion Daily S&P Biotech Bear 3X Shares seek daily investment results, before fees and expenses, of 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. This leveraged ETF seeks a return that is -300% the return of its benchmark index for a single day
- Featured in 1 curated theme
- 16 holdings
- Ticker
- LABD
- Exchange
- NYSE Arca
- ISIN
- US25460G7161
- CUSIP
- 25460G716
- Currency
- U.S. Dollar (USD)
- Country
- USA
- Sector
- Health Care
- Industry
- Inverse
- Benchmark
- S&P Biotechnology Select Industry Index
All key statistics
Details
Shareas of Oct 12, 2026
Dataas of Feb 27, 2020
Put LABD to the test
See how it would change the return and the risk of a portfolio, with virtual money, before a single real dollar moves.
Data for information only, not investment advice. Past performance does not guarantee future results.